162 related articles for article (PubMed ID: 20537649)
1. Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency.
Nuño-Ayala M; Guillén N; Navarro MA; Lou-Bonafonte JM; Arnal C; Gascón S; Barranquero C; Godino J; Royo-Cañas M; Sarría AJ; Guzmán MA; Hernandez E; Bregante MA; García-Gimeno MA; Osada J
Atherosclerosis; 2010 Sep; 212(1):268-73. PubMed ID: 20537649
[TBL] [Abstract][Full Text] [Related]
2. Taurine-deficient diet up-regulated cystathionine beta-synthase monoallele in hemizygous cystathionine beta-synthase knockout mice.
Chao WH; Reynolds RD
Nutr Res; 2009 Nov; 29(11):794-801. PubMed ID: 19932868
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice.
Hamelet J; Demuth K; Paul JL; Delabar JM; Janel N
J Hepatol; 2007 Jan; 46(1):151-9. PubMed ID: 17030070
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice.
Noll C; Hamelet J; Ducros V; Belin N; Paul JL; Delabar JM; Janel N
Food Chem Toxicol; 2009 Jan; 47(1):230-6. PubMed ID: 19028542
[TBL] [Abstract][Full Text] [Related]
5. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.
Namekata K; Enokido Y; Ishii I; Nagai Y; Harada T; Kimura H
J Biol Chem; 2004 Dec; 279(51):52961-9. PubMed ID: 15466479
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.
Liao D; Tan H; Hui R; Li Z; Jiang X; Gaubatz J; Yang F; Durante W; Chan L; Schafer AI; Pownall HJ; Yang X; Wang H
Circ Res; 2006 Sep; 99(6):598-606. PubMed ID: 16931800
[TBL] [Abstract][Full Text] [Related]
7. Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport.
Julve J; Escolà-Gil JC; Rodríguez-Millán E; Martín-Campos JM; Jauhiainen M; Quesada H; Rentería-Obregón IM; Osada J; Sánchez-Quesada JL; Blanco-Vaca F
Mol Nutr Food Res; 2013 Oct; 57(10):1814-24. PubMed ID: 23754667
[TBL] [Abstract][Full Text] [Related]
8. [Alterations in the protein content and dysfunction of high-density lipoproteins from hyperhomocysteinemic mice].
Julve J; Errico TL; Chen X; Santos D; Freixa J; Porcel I; Cubero E; Escolà-Gil JC; Blanco-Vaca F
Clin Investig Arterioscler; 2013; 25(4):164-73. PubMed ID: 23938051
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: possible implications for cardiovascular outcomes.
Jiang H; Stabler SP; Allen RH; Maclean KN
Mol Genet Metab; 2012 Sep; 107(1-2):55-65. PubMed ID: 22633282
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific Dyrk1a gene transfer rescues plasma apolipoprotein A-I levels and aortic Akt/GSK3 pathways in hyperhomocysteinemic mice.
Tlili A; Jacobs F; de Koning L; Mohamed S; Bui LC; Dairou J; Belin N; Ducros V; Dubois T; Paul JL; Delabar JM; De Geest B; Janel N
Biochim Biophys Acta; 2013 Jun; 1832(6):718-28. PubMed ID: 23429073
[TBL] [Abstract][Full Text] [Related]
11. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.
Mikael LG; Genest J; Rozen R
Circ Res; 2006 Mar; 98(4):564-71. PubMed ID: 16439690
[TBL] [Abstract][Full Text] [Related]
12. Genetic background conversion ameliorates semi-lethality and permits behavioral analyses in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia.
Akahoshi N; Kobayashi C; Ishizaki Y; Izumi T; Himi T; Suematsu M; Ishii I
Hum Mol Genet; 2008 Jul; 17(13):1994-2005. PubMed ID: 18364386
[TBL] [Abstract][Full Text] [Related]
13. Hepatic cystathionine beta-synthase activity does not increase in response to methionine supplementation in rats fed a low casein diet: association with plasma homocysteine concentrations.
Ohuchi S; Morita T; Mori M; Sugiyama K
J Nutr Sci Vitaminol (Tokyo); 2009 Apr; 55(2):178-85. PubMed ID: 19436145
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice.
Dayal S; Bottiglieri T; Arning E; Maeda N; Malinow MR; Sigmund CD; Heistad DD; Faraci FM; Lentz SR
Circ Res; 2001 Jun; 88(11):1203-9. PubMed ID: 11397788
[TBL] [Abstract][Full Text] [Related]
15. Hepatic acyl-coenzyme a:cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia.
Devlin AM; Singh R; Bottiglieri T; Innis SM; Green TJ
J Nutr; 2010 Feb; 140(2):231-7. PubMed ID: 20018805
[TBL] [Abstract][Full Text] [Related]
16. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice.
Noll C; Hamelet J; Matulewicz E; Paul JL; Delabar JM; Janel N
J Nutr Biochem; 2009 Aug; 20(8):586-96. PubMed ID: 18676137
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
18. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice.
Lentz SR; Erger RA; Dayal S; Maeda N; Malinow MR; Heistad DD; Faraci FM
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H970-5. PubMed ID: 10993757
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine increases the risk associated with hyperlipidaemia.
Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
[TBL] [Abstract][Full Text] [Related]
20. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway.
Alberto JM; Hamelet J; Noll C; Blaise S; Bronowicki JP; Guéant JL; Delabar JM; Janel N
Mol Genet Metab; 2007 Aug; 91(4):396-8. PubMed ID: 17562377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
